CLPT NASDAQ
ClearPoint Neuro, Inc.
1W: +2.5%
1M: -36.7%
3M: -31.5%
YTD: -30.9%
1Y: -60.8%
3Y: +99.8%
5Y: -47.2%
$9.69
+0.65 (+7.19%)
Weekly Expected Move ±13.7%
$7
$8
$9
$10
$12
Credit Risk of going bust: higher than 79% of companies Debt: 18.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.27 (down 97%), ClearPoint Neuro, Inc. would be worth roughly what it owes.
Total debt $63.9M against a stock market value of $275.8M.
Distance to default 2.68 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $25.3M (short-term plus half of long-term), stock volatility 88.5%; Altman Z -1.81. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.27 (down 97%), ClearPoint Neuro, Inc. would be worth roughly what it owes.
Total debt $63.9M against a stock market value of $275.8M.
Distance to default 2.68 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $25.3M (short-term plus half of long-term), stock volatility 88.5%; Altman Z -1.81. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.45
Bullish
1 bullish
1 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (43)
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
What is Lake Street Capital’s Estimate for CLPT Q3 Earnings?
Cedar Grove Capital Q3: Adds Zedcor, Auxly; exits MTY, ClearPoint
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
ClearPoint Neuro outlines $48M-$52M 2026 revenue guidance as it prioritizes CAL, clinical capacity, and focused ultrasound partnership
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
Mettler-Toledo (MTD) Q2 Earnings Surpass Estimates
Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for
OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last?
10 small-cap U.S. healthcare stocks with the strongest momentum grades
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
12 Health Care Stocks Moving In Wednesday's Intraday Session
Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
ClearPoint (CLPT) Q1 2026 Earnings Transcript
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
UFP Technologies (UFPT) Tops Q1 Earnings Estimates
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3% – Should You Sell?
Crude Oil Moves Higher; Jabil Shares Slide After Q2 Results
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition
ClearPoint Neuro (CLPT) Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
ClearPoint Neuro, Inc. reports Q4 results
Here are the major earnings after the close Tuesday
Earnings Scheduled For March 17, 2026
ClearPoint Neuro, Inc. Q4 2025 Earnings Preview
ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?
12 Health Care Stocks Moving In Monday's Intraday Session
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
ClearPoint Neuro: From Validation To Scale
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
ClearPoint Neuro Completes Acquisition of IRRAS